| Product Code: ETC7351786 | Publication Date: Sep 2024 | Updated Date: Nov 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
In the Greece large molecule drug substance CDMO market, the import trend showed a modest growth rate of 0.61% from 2023 to 2024, with a notable compound annual growth rate (CAGR) of 12.53% for the period of 2020-2024. This upward import momentum can be attributed to a consistent demand shift towards specialized drug manufacturing services in the region.
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Greece Large Molecule Drug Substance CDMO Market Overview |
3.1 Greece Country Macro Economic Indicators |
3.2 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, 2021 & 2031F |
3.3 Greece Large Molecule Drug Substance CDMO Market - Industry Life Cycle |
3.4 Greece Large Molecule Drug Substance CDMO Market - Porter's Five Forces |
3.5 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Service, 2021 & 2031F |
3.6 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By Source, 2021 & 2031F |
3.7 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 Greece Large Molecule Drug Substance CDMO Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing demand for large molecule drug substances outsourcing due to cost-effectiveness and efficiency. |
4.2.2 Growing research and development activities in the pharmaceutical industry in Greece. |
4.2.3 Favorable government regulations supporting the growth of contract development and manufacturing organizations (CDMOs) in the country. |
4.3 Market Restraints |
4.3.1 Intense competition among existing CDMOs in Greece. |
4.3.2 Challenges related to maintaining quality standards and regulatory compliance. |
4.3.3 Potential supply chain disruptions affecting the production and delivery of large molecule drug substances. |
5 Greece Large Molecule Drug Substance CDMO Market Trends |
6 Greece Large Molecule Drug Substance CDMO Market, By Types |
6.1 Greece Large Molecule Drug Substance CDMO Market, By Service |
6.1.1 Overview and Analysis |
6.1.2 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Service, 2021- 2031F |
6.1.3 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Manufacturing, 2021- 2031F |
6.1.4 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Clinical, 2021- 2031F |
6.1.5 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Commercial, 2021- 2031F |
6.1.6 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Contract Development, 2021- 2031F |
6.1.7 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Cell Line Development, 2021- 2031F |
6.1.8 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Process Development, 2021- 2031F |
6.2 Greece Large Molecule Drug Substance CDMO Market, By Source |
6.2.1 Overview and Analysis |
6.2.2 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Mammalian, 2021- 2031F |
6.2.3 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Microbial, 2021- 2031F |
6.2.4 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
6.3 Greece Large Molecule Drug Substance CDMO Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Biotech Companies, 2021- 2031F |
6.3.3 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By CRO, 2021- 2031F |
6.3.4 Greece Large Molecule Drug Substance CDMO Market Revenues & Volume, By Others, 2021- 2031F |
7 Greece Large Molecule Drug Substance CDMO Market Import-Export Trade Statistics |
7.1 Greece Large Molecule Drug Substance CDMO Market Export to Major Countries |
7.2 Greece Large Molecule Drug Substance CDMO Market Imports from Major Countries |
8 Greece Large Molecule Drug Substance CDMO Market Key Performance Indicators |
8.1 Percentage of new partnerships and collaborations formed with pharmaceutical companies. |
8.2 Number of successfully completed projects within the specified timelines. |
8.3 Rate of adoption of innovative technologies and processes in large molecule drug substance manufacturing. |
9 Greece Large Molecule Drug Substance CDMO Market - Opportunity Assessment |
9.1 Greece Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Service, 2021 & 2031F |
9.2 Greece Large Molecule Drug Substance CDMO Market Opportunity Assessment, By Source, 2021 & 2031F |
9.3 Greece Large Molecule Drug Substance CDMO Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 Greece Large Molecule Drug Substance CDMO Market - Competitive Landscape |
10.1 Greece Large Molecule Drug Substance CDMO Market Revenue Share, By Companies, 2024 |
10.2 Greece Large Molecule Drug Substance CDMO Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |